No abstract

Economically, the iStent would appear to be a reasonably cost-effective treatment for glaucoma patients undergoing cataract surgery in a public healthcare setting in New Zealand, particularly for those using more expensive topical glaucoma medications, whilst SLT appears to be a worthwhile consideration as a first-line treatment for glaucoma in New Zealand.

No abstract

Figure 1 Clinical photograph of the superotemporal fundus showing five linear retinal tears. Retinal tear following closed trauma with a toy balloonEA Fraser and CJ Diaper 228 Eye

No abstract